Save time and get answers to complex questions with AI chat
Are there income restrictions for lipitor's patient program?Complera manufacturer?Cost promethazine price?Patent term adjustment semaglutida?Novartis patent term dabrafenib?
See the DrugPatentWatch profile for Prolia
Prolia (denosumab) received regulatory approval first in the European Union (as “Prolia”) on 26 May 2010.[1]
The U.S. approval (for Prolia) followed later; the FDA approval date was June 1, 2010.[2]
Approval dates vary because each regulator (e.g., FDA vs. EMA) reviews and grants authorization on its own timeline, based on submission timing and review schedules.
Other Questions About Prolia :